EP3585437
COMBINATIONS OF COPANLISIB WITH ANTI-PD-1 ANTIBODY
:
EP einkaleyfi: Þýðing ekki lögð inn:
22.2.2018:
21.12.2022:
18707340.8
:
21.2.2038
:
COMBINATIONS OF COPANLISIB WITH ANTI-PD-1 ANTIBODY
22.2.2018
21.12.2022
:
Bayer Pharma Aktiengesellschaft:
Müllerstrasse 178, 13353 Berlin, DE
:
NINGSHU, Liu:
12203 Berlin, DE
:
17157835:
24.2.2017:
EP
:
EP2018054376:
22.2.2018
:
A61K 31/5377, A61K 31/519, A61K 45/06, C07K 16/28, A61P 35/00, C07K 16/00, A61K 39/395